| Cold infusion | Nasopharyngeal cooling | P-value |
---|---|---|---|
Patients; number | 10 | 10 | Â |
Female; number (%) | 4 (40%) | 5 (50%) | n.s.a |
Age, years; mean ± STD | 65.4 ± 7.4 | 55.7 ± 11.5 | 0.038b |
Weight, kg | 83.5 ± 17.7 | 80.3 ± 12.7 | n.s.b |
Height, cm | 173.1 ± 10.1 | 172 ± 10 | n.s.b |
Body mass index, kg/m2 | 27.9 ± 5.9 | 27.3 ± 2.4 | n.s.b |
Body surface aread, m2 | 2 ± 0.2 | 2 ± 0.2 | n.s.b |
Time from symptom onset to treatment, hours | 69.4 ± 25.2 | 67.1 ± 31.9 | n.s.b |
Stroke type; number (%) | Â | Â | n.s.a |
Ischaemic | 7 (70%) | 4 (40%) | Â |
ICH | 2 (20%) | 5 (50%) | Â |
SAH | 1 (10%) | 1 (10%) | Â |
Scores | Â | Â | Â |
Premorbid mRS; number (%) | Â | Â | n.s.c |
0 | 7 (70%) | 7 (70%) | Â |
1 | 2 (20%) | 2 (20%) | Â |
2 | 1 (10%) | 1 (10%) | Â |
NIHSS admission; median (IQR) | 14.5 (6.75-24.75) | 26.5 (17.5-38) | n.s.c |
mRS follow-up median (IQR) | 4.5 (3.75-6) | 4.5 (3-6) | n.s.c |
Risk factors; number (%) | Â | Â | Â |
Diabetes mellitus | 0 (0%) | 3 (30%) | n.s.a |
Arterial hypertension | 8 (80%) | 8 (80%) | n.s.a |
Hypercholesterolaemia | 0 (0%) | 1 (10%) | n.s.a |
Atrial fibrillation | 2 (20%) | 0 (0%) | n.s.a |